Kanagawa, Japan

Toshihiro Watari

This inventor holds 1 USPTO granted patent. Top assignee: Hitachi Chemical Company, Ltd.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshihiro Watari

Introduction

Toshihiro Watari is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of equine interleukin-1.

Latest Patents

Watari holds a patent for "DNA encoding equine interleukin-1." This patent discloses an equine interleukin-1 peptide that comprises a sequence of at least five continuous amino acids represented by SEQ ID NO: 1 or NO: 2 in the sequence listing. The patent also includes DNA coding for the equine interleukin-1 peptide, a recombinant vector containing the DNA, a transformant with the recombinant vector, and a process for preparing an anti-equine interleukin-1 antibody using the equine interleukin-1 peptide as an antigen. He has 1 patent to his name.

Career Highlights

Toshihiro Watari is associated with Hitachi Chemical Company, Ltd., where he applies his expertise in biotechnology. His work has contributed to advancements in the understanding and application of interleukin-1 in equine health.

Collaborations

Watari has collaborated with notable colleagues such as Noriko Nakamura and Shigeyoshi Takagi, enhancing the research and development efforts within his field.

Conclusion

Toshihiro Watari's innovative work in biotechnology, particularly with equine interleukin-1, showcases his commitment to advancing scientific knowledge and applications. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…